This report focuses on the global Recombinant DNA (rDNA) Technology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Recombinant DNA (rDNA) Technology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study F. Hoffmann-La Roche Ltd (Genentech, Inc) Profacgen Amgen Inc Novartis AG GenScript Pfizer Inc Novo Nordisk A/S Eli Lilly and Company Sanofi Biocon GlaxoSmithKline plc New England Biolabs. Cibus Monsanto Company Horizon Discovery Group PLC Market segment by Component, the product can be split into Expression System Cloning Vector Market segment by Application, split into Biotechnology and Pharmaceutical Companies Academic and Government Research Institutes Other Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Recombinant DNA (rDNA) Technology status, future forecast, growth opportunity, key market and key players. To present the Recombinant DNA (rDNA) Technology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by component, market and key regions. In this study, the years considered to estimate the market size of Recombinant DNA (rDNA) Technology are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, component and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
This research study involves broad usage of both secondary and primary data sources. The research process involves the identification of numerous factors which affect the industry, comprising the market environment, government policy, historical data, present trends in the market, competitive landscape, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.
Market Estimation
Top-down and bottom-up approaches are used for validating the market size for companies, regional segments along with relevant market segmentations such as product type and application.
This report includes market estimations which are based on the marketed sale price of a product. Further breakdown of product segments, particular market share are formed based on the weightage assigned to every segment, which is derived of their usage rate and average price. The entire probable factors which effect the markets and influence them in a great way are included in this research report; and have been accounted for, studied in-depth and are confirmed through primary research. These are then studies to get the final qualitative and quantitative data. Any of the factors such as the outcome of inflation, economic downfall, and any kind of policy and regulatory alterations and/or other such factors are not accounted for in the market forecast. All of this data is amalgamated and included with thorough inputs and analysis from Gravitas Market Insights is curated in this report.
Along with the previously mentioned approaches, various data triangulation methods, in order to conduct market estimations and market forecasting for the complete market segments are detailed in this report. Key Companies present in the said market are also acknowledged via in-depth secondary research and primary research.
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Recombinant DNA (rDNA) Technology Revenue 1.4 Covid-19 Implications on Market by Component 1.4.1 Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Component: 2020 VS 2026 1.4.2 Expression System 1.4.3 Cloning Vector 1.5 Covid-19 Implications on Market by Application 1.5.1 Global Recombinant DNA (rDNA) Technology Market Share by Application: 2020 VS 2026 1.5.2 Biotechnology and Pharmaceutical Companies 1.5.3 Academic and Government Research Institutes 1.5.4 Other 1.6 Coronavirus Disease 2019 (Covid-19): Recombinant DNA (rDNA) Technology Industry Impact 1.6.1 How the Covid-19 is Affecting the Recombinant DNA (rDNA) Technology Industry 1.6.1.1 Recombinant DNA (rDNA) Technology Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19?s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Recombinant DNA (rDNA) Technology Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Recombinant DNA (rDNA) Technology Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Covid-19 Implications on Global Recombinant DNA (rDNA) Technology Market Perspective (2015-2026) 2.2 Covid-19 Implications on Global Recombinant DNA (rDNA) Technology Growth Trends by Regions 2.2.1 Recombinant DNA (rDNA) Technology Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Recombinant DNA (rDNA) Technology Historic Market Share by Regions (2015-2020) 2.2.3 Recombinant DNA (rDNA) Technology Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter?s Five Forces Analysis 2.3.5 Recombinant DNA (rDNA) Technology Market Growth Strategy 2.3.6 Primary Interviews with Key Recombinant DNA (rDNA) Technology Players (Opinion Leaders) 3 Covid-19 Implications on Competition Landscape by Key Players 3.1 Global Top Recombinant DNA (rDNA) Technology Players by Market Size 3.1.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue (2015-2020) 3.1.2 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Players (2015-2020) 3.1.3 Global Recombinant DNA (rDNA) Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio 3.2.1 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Recombinant DNA (rDNA) Technology Revenue in 2019 3.3 Recombinant DNA (rDNA) Technology Key Players Head office and Area Served 3.4 Key Players Recombinant DNA (rDNA) Technology Product Solution and Service 3.5 Date of Enter into Recombinant DNA (rDNA) Technology Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Covid-19 Implications on Market Size by Component (2015-2026) 4.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Component (2015-2020) 4.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Component (2021-2026) 5 Covid-19 Implications on Market Size by Application (2015-2026) 5.1 Global Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) 5.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Recombinant DNA (rDNA) Technology Market Size (2015-2020) 6.2 Recombinant DNA (rDNA) Technology Key Players in North America (2019-2020) 6.3 North America Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) 6.4 North America Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) 7 Europe 7.1 Europe Recombinant DNA (rDNA) Technology Market Size (2015-2020) 7.2 Recombinant DNA (rDNA) Technology Key Players in Europe (2019-2020) 7.3 Europe Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) 7.4 Europe Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) 8 China 8.1 China Recombinant DNA (rDNA) Technology Market Size (2015-2020) 8.2 Recombinant DNA (rDNA) Technology Key Players in China (2019-2020) 8.3 China Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) 8.4 China Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) 9 Japan 9.1 Japan Recombinant DNA (rDNA) Technology Market Size (2015-2020) 9.2 Recombinant DNA (rDNA) Technology Key Players in Japan (2019-2020) 9.3 Japan Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) 9.4 Japan Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Recombinant DNA (rDNA) Technology Market Size (2015-2020) 10.2 Recombinant DNA (rDNA) Technology Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020) 10.4 Southeast Asia Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) 11 India 11.1 India Recombinant DNA (rDNA) Technology Market Size (2015-2020) 11.2 Recombinant DNA (rDNA) Technology Key Players in India (2019-2020) 11.3 India Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020) 11.4 India Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Recombinant DNA (rDNA) Technology Market Size (2015-2020) 12.2 Recombinant DNA (rDNA) Technology Key Players in Central & South America (2019-2020) 12.3 Central & South America Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020) 12.4 Central & South America Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) 13Key Players Profiles 13.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) 13.1.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details 13.1.2 F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview and Its Total Revenue 13.1.3 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Introduction 13.1.4 F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)) 13.1.5 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development 13.2 Profacgen 13.2.1 Profacgen Company Details 13.2.2 Profacgen Business Overview and Its Total Revenue 13.2.3 Profacgen Recombinant DNA (rDNA) Technology Introduction 13.2.4 Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) 13.2.5 Profacgen Recent Development 13.3 Amgen Inc 13.3.1 Amgen Inc Company Details 13.3.2 Amgen Inc Business Overview and Its Total Revenue 13.3.3 Amgen Inc Recombinant DNA (rDNA) Technology Introduction 13.3.4 Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) 13.3.5 Amgen Inc Recent Development 13.4 Novartis AG 13.4.1 Novartis AG Company Details 13.4.2 Novartis AG Business Overview and Its Total Revenue 13.4.3 Novartis AG Recombinant DNA (rDNA) Technology Introduction 13.4.4 Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) 13.4.5 Novartis AG Recent Development 13.5 GenScript 13.5.1 GenScript Company Details 13.5.2 GenScript Business Overview and Its Total Revenue 13.5.3 GenScript Recombinant DNA (rDNA) Technology Introduction 13.5.4 GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) 13.5.5 GenScript Recent Development 13.6 Pfizer Inc 13.6.1 Pfizer Inc Company Details 13.6.2 Pfizer Inc Business Overview and Its Total Revenue 13.6.3 Pfizer Inc Recombinant DNA (rDNA) Technology Introduction 13.6.4 Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) 13.6.5 Pfizer Inc Recent Development 13.7 Novo Nordisk A/S 13.7.1 Novo Nordisk A/S Company Details 13.7.2 Novo Nordisk A/S Business Overview and Its Total Revenue 13.7.3 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Introduction 13.7.4 Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) 13.7.5 Novo Nordisk A/S Recent Development 13.8 Eli Lilly and Company 13.8.1 Eli Lilly and Company Company Details 13.8.2 Eli Lilly and Company Business Overview and Its Total Revenue 13.8.3 Eli Lilly and Company Recombinant DNA (rDNA) Technology Introduction 13.8.4 Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) 13.8.5 Eli Lilly and Company Recent Development 13.9 Sanofi 13.9.1 Sanofi Company Details 13.9.2 Sanofi Business Overview and Its Total Revenue 13.9.3 Sanofi Recombinant DNA (rDNA) Technology Introduction 13.9.4 Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) 13.9.5 Sanofi Recent Development 13.10 Biocon 13.10.1 Biocon Company Details 13.10.2 Biocon Business Overview and Its Total Revenue 13.10.3 Biocon Recombinant DNA (rDNA) Technology Introduction 13.10.4 Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) 13.10.5 Biocon Recent Development 13.11 GlaxoSmithKline plc 10.11.1 GlaxoSmithKline plc Company Details 10.11.2 GlaxoSmithKline plc Business Overview and Its Total Revenue 10.11.3 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Introduction 10.11.4 GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) 10.11.5 GlaxoSmithKline plc Recent Development 13.12 New England Biolabs. 10.12.1 New England Biolabs. Company Details 10.12.2 New England Biolabs. Business Overview and Its Total Revenue 10.12.3 New England Biolabs. Recombinant DNA (rDNA) Technology Introduction 10.12.4 New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) 10.12.5 New England Biolabs. Recent Development 13.13 Cibus 10.13.1 Cibus Company Details 10.13.2 Cibus Business Overview and Its Total Revenue 10.13.3 Cibus Recombinant DNA (rDNA) Technology Introduction 10.13.4 Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) 10.13.5 Cibus Recent Development 13.14 Monsanto Company 10.14.1 Monsanto Company Company Details 10.14.2 Monsanto Company Business Overview and Its Total Revenue 10.14.3 Monsanto Company Recombinant DNA (rDNA) Technology Introduction 10.14.4 Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) 10.14.5 Monsanto Company Recent Development 13.15 Horizon Discovery Group PLC 10.15.1 Horizon Discovery Group PLC Company Details 10.15.2 Horizon Discovery Group PLC Business Overview and Its Total Revenue 10.15.3 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Introduction 10.15.4 Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) 10.15.5 Horizon Discovery Group PLC Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details
